Health Care & Life Sciences » Pharmaceuticals | Hebei Changshan Biochemical Pharmaceutical Co. Ltd.

Hebei Changshan Biochemical Pharmaceutical Co. Ltd. | Mutual Funds

Mutual Funds that own Hebei Changshan Biochemical Pharmaceutical Co. Ltd.

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
3,739,548
0.63%
3,739,548
2.56%
12/31/2017
283,500
0.05%
283,500
0.15%
12/31/2017
281,143
0.05%
-2,700
0.81%
12/31/2017
Fidelity Strategic Advisers Emerging Markets Fund
274,235
0.05%
0
0%
07/31/2018
268,300
0.05%
268,300
0.05%
12/31/2017
112,900
0.02%
112,900
0.09%
12/31/2017
85,800
0.01%
85,800
0.14%
12/31/2016
22,500
0%
22,500
0.27%
12/31/2017
18,600
0%
18,600
0.11%
12/31/2017
SME & CHINEXT 400 ETF
17,500
0%
17,500
0.11%
12/31/2017

About Hebei Changshan Biochemical Pharmaceutical Co.

View Profile
Address
North End of Yinchuan Avenue
Shijiazhuang Hebei 050800
China
Employees -
Website http://www.heparin.cn
Updated 07/08/2019
Hebei Changshan Biochemical Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of heparin active pharmaceutical ingredient (API) and heparin preparations. Its products include heparin raw materials, heparin sodium injection, enoxaparin sodium API, heparin sodium raw materials, low molecular weight heparin calcium drug, enoxaparin sodium injection, and low molecular weight heparin calcium injection. The company was founded on September 28, 2000 and is headquartered in Shijiazhuang, China.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.